These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Isolated Tongue Angioedema after Alteplase Infusion in Acute Ischemic Stroke. Pisani E; Gaudiano C; Petrone A; Stancati F; Siniscalchi A Curr Drug Saf; 2022; 17(1):75-77. PubMed ID: 34323196 [TBL] [Abstract][Full Text] [Related]
49. A model to prevent fibrinolysis in patients with stroke mimics. Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609 [TBL] [Abstract][Full Text] [Related]
50. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. Hill MD; Barber PA; Takahashi J; Demchuk AM; Feasby TE; Buchan AM CMAJ; 2000 May; 162(9):1281-4. PubMed ID: 10813008 [TBL] [Abstract][Full Text] [Related]
52. Gastrointestinal Angioedema as a Side Effect of Alteplase for Acute Stroke. Yakhkind A; Lang AE; Montalvo M; Beland MD; Cutting S J Vasc Interv Radiol; 2020 Nov; 31(11):1921-1924. PubMed ID: 32636132 [No Abstract] [Full Text] [Related]
53. [Treatment of alteplase-induced orolingual angioedema by means of icatibant]. Mas-Serrano M; Garcia-Pastor A; Tornero-Molina P; Vazquez-Alen P; Palacios-Mendoza MA; Gil-Nunez AC Rev Neurol; 2019 Sep; 69(6):261-262. PubMed ID: 31497871 [TBL] [Abstract][Full Text] [Related]
54. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Al-Khaled M; Matthis C; Eggers J J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915 [TBL] [Abstract][Full Text] [Related]
55. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis. Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320 [TBL] [Abstract][Full Text] [Related]
56. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy. Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718 [TBL] [Abstract][Full Text] [Related]
58. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Nathaniel TI; Cochran T; Chaves J; Fulmer E; Sosa C; Yi S; Fredwall M; Sternberg S; Blackhurst D; Nelson A; Leacock R Brain Inj; 2016; 30(10):1261-5. PubMed ID: 27484159 [TBL] [Abstract][Full Text] [Related]
59. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan. Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772 [TBL] [Abstract][Full Text] [Related]